收藏切换
Current research status on psoralen flavonoids for treating bone and joint diseases
收藏切换
PDF
Ze-yang ZHANG1, ABUDUKEREMU Dawuti1, Yu-lin JIN1, Hui ZHAO2, Qi FU2, Chao ZHANG2
Chinese Journal of Clinical Pharmacology | 2026, 42(4) : 573 - 580
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2026, 42(4): 573-580
Review
Current research status on psoralen flavonoids for treating bone and joint diseases
Full
Ze-yang ZHANG1, ABUDUKEREMU Dawuti1, Yu-lin JIN1, Hui ZHAO2, Qi FU2, Chao ZHANG2
Affiliations
  • 1.The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu Province, China
  • 2.The First Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, China
Published: 2026-02-28 doi: 10.13699/j.cnki.1001-6821.2026.04.019
Outline
收藏切换

Bone and joint diseases encompass conditions such as osteoporosis, osteoarthritis, rheumatoid arthritis, and gouty arthritis. With high prevalence rates and a significant burden of disability, they have become a major global public health issue. Current treatment approaches primarily rely on drug interventions and surgical procedures, with relatively limited options for comprehensive intervention strategies. Psoralea corylifolia L. (Buguzhi), a traditional Chinese medicinal herb, is rich in various flavonoid small-molecule compounds. Its multi-targeted, multi-step regulatory advantages have drawn significant attention in the prevention and treatment of bone and joint diseases. Existing evidence indicates that these compounds exhibit comprehensive effects including osteogenesis promotion, osteoclast inhibition, anti-inflammation, antioxidant activity, and metabolic regulation, However, its key active substances and functional networks have yet to be systematically elucidated. Based on this, this paper aims to systematically elucidate the pharmacological actions and molecular mechanisms of psoralen flavonoids in the treatment of osteoarthritis, with the goal of providing novel research perspectives and potential strategies for the clinical prevention and treatment of this condition. Furthermore, it explores the prospects for clinical translation and the primary challenges encountered.

Psoralea corylifolia L.  /  flavonoids  /  osteoporosis  /  osteoarthritis  /  rheumatoid arthritis  /  gouty arthritis
Ze-yang ZHANG, ABUDUKEREMU Dawuti, Yu-lin JIN, Hui ZHAO, Qi FU, Chao ZHANG. Current research status on psoralen flavonoids for treating bone and joint diseases[J]. Chinese Journal of Clinical Pharmacology, 2026 , 42 (4) : 573 -580 . DOI: 10.13699/j.cnki.1001-6821.2026.04.019
Year 2026 volume 42 Issue 4
PDF
121
33
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2026.04.019
  • Receive Date:2025-12-01
  • Online Date:2026-08-06
  • Published:2026-02-28
Article Data
Affiliations
History
  • Received:2025-12-01
Funding
Affiliations
    1.The First Clinical Medical College of Lanzhou University, Lanzhou 730000, Gansu Province, China
    2.The First Hospital of Lanzhou University, Lanzhou 730030, Gansu Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2026.04.019
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT